Surgical Science Sweden AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was SEK 205.08 million compared to SEK 95.32 million a year ago. Net income was SEK 28.5 million compared to SEK 14.37 million a year ago. Basic earnings per share from continuing operations was SEK 0.56 compared to SEK 0.33 a year ago. Diluted earnings per share from continuing operations was SEK 0.56 compared to SEK 0.32 a year ago.
For the nine months, sales was SEK 552.43 million compared to SEK 169.08 million a year ago. Net income was SEK 71.45 million compared to SEK 19.36 million a year ago. Basic earnings per share from continuing operations was SEK 1.41 compared to SEK 0.49 a year ago. Diluted earnings per share from continuing operations was SEK 1.4 compared to SEK 0.49 a year ago.